Erlend Skaga

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.

Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.

Journal: Journal of neuro-oncology

Published: January 19, 2026

Drug resistant glioblastoma stem cells exhibit enriched stemness signatures and share extracellular matrix overexpression.

Drug resistant glioblastoma stem cells exhibit enriched stemness signatures and share extracellular matrix overexpression.

Journal: BMC cancer

Published: June 12, 2025

Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.

Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.

Journal: Journal of neuro-oncology

Published: May 06, 2025

The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study.

The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study.

Journal: Neuro-oncology practice

Published: November 29, 2023

Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling.

Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling.

Journal: Cancers

Published: November 07, 2023

Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study.

Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 03, 2023

Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome.

Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome.

Journal: Translational oncology

Published: May 30, 2022

Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

Journal: Neuro-oncology advances

Published: March 05, 2021

A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.

A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.

Journal: Cancers

Published: May 31, 2020

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.

Journal: Clinical and translational medicine

Published: November 03, 2019

HMGB1 concentration measurements in trauma patients: assessment of pre-analytical conditions and sample material.

HMGB1 concentration measurements in trauma patients: assessment of pre-analytical conditions and sample material.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 18, 2019

Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem Cells.

Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem Cells.

Journal: Journal of proteome research

Published: April 10, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026